Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Germany
since 2007 – Director, Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Germany
since 2007 – Full Professor (Cardiology/Adult Congenital Heart Disease), University of Muenster, Germany
1993 – 2007 Staff cardiologist, Dept. of Cardiology, Medical University – Vienna General Hospital
1993 – 2007 Professor of Medicine / Cardiology, Medical University of Vienna
1993 – 2007 Director, Adult Congenital Heart Disease and Acquired Valvular Heart Disease Program, Medical University of Vienna
1993 – 2007 Director, Research Program on Adult Congenital Heart Disease and Acquired Valvular Heart Disease, Medical University of Vienna
1993 – 2007 Director, In-Vitro Echocardiography Research Laboratory
1993 – 2001 Director, Echocardiography Laboratory, Dept. of Cardiology, Medical University of Vienna
1992 – 1993 Staff cardiologist and Director, Echocardiography Laboratory, 2nd Department of Internal Medicine / Cardiology, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
1981 – 1983 Internship, Krankenhaus der Barmherzigen Schwestern , Linz and St. Pölten General Hospital, Austria
1994 – 1989 Residency/Fellowship, Internal Medicine; 1st and 2nd Dept. of Internal Medicine, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
1989 – 1990 Research Fellowship, Division of Cardiology, Cedars-Sinai Medical Center, University of California at Los Angeles, Los Angeles, USA
1990 – 1991 Clinical Fellowship in Cardiology; 2nd Dept. of Internal Medicine / Cardiology, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
Clinical and basic research in the area of valvular heart disease and congenital heart disease
Clinical and experimental research in echocardiography
Catheter intervention in congenital and acquired valvular heart disease Myocardial viability
More than 250 publications, of these more than 150 papers in peer-reviewed journals
Medical Societies / Fellowships / Journals (selected)
Austrian Society of Cardiology: Chairman of the working group on adult congenital heart disease; President of the Society 2005-2007
European Society of Cardiology: Board member 2006-2008; Nucleus member of the working group on grown-up congenital heart disease, co-chairman 2004-2006, chairman 2006–2008, past-chairman 2008-2010, Chairman, TF Practice guidelines on the management of grown-up congenital heart disease, Task forces and committees (Practice guidelines on the management of valvular heart disease, Education committee, Accreditation committee), Clinical Practice Guidelines Committee (2010-2014),Congress Programme Committee (2010-2014)
Arrhythmia and Electrophysiology Research Center, IRCCS Humanitas Research Hospital, Milan, Italy
Dr. Cappato received his degree in medicine from the University of Ferrara in 1983 and he was co-director of the EP-Lab at Eppendorf University and St. Georg General Hospital, Hamburg (Germany) between 1993 and 2000. He is experienced in the management of supraventricular and ventricular arrhythmias and in their treatment with trans-catheter radiofrequency ablation. He is a fellow of the European Society of Cardiology and the Heart Rhythm Society. He is the current President of the European Cardiac Arrhythmia Society (ECAS) and co-director of the Europe AF Congress since 2007. Dr. Cappato is a patent inventor of the Subcutaneous ICD developed by Cameron Health. He is principal investigator of X-Vert (exploring the efficacy and safety of once-daily oral rivaroxaban for the prevention of cardiovascular events in subjects with nonvalvular AF scheduled for cardioversion), VENTURE AF ablation study, chief investigator of Optimise (Omacor plus standard therapies in port MI subjects evaluation) and leading investigator of a patient-based worldwide AF ablation survey. He has published more than 300 peer reviewed manuscripts and book chapters and is on the editorial board of several Cardiology Journals. Frequently he serves as invited lecturer in major international scientific meetings.
Royal Brompton and Harefield NHS Foundation Trust, London, UK
Martin Cowie is Professor of Cardiology (Health Services Research) and is an Honorary Consultant Cardiologist at the Royal Brompton and Harefield NHS Foundation Trust.
After qualifying from the University of Aberdeen in 1989, Professor Cowie trained in London in cardiology and epidemiology, undertaking a MSc in Epidemiology at the London School of Hygiene and Tropical Medicine. His MD related to work on the epidemiology of heart failure in the UK. After a brief period back in Scotland, he returned to Imperial College in 2001, taking up the Chair of Cardiology (Health Services Research) at the National Heart & Lung Institute, with his clinical practice based at the Royal Brompton Hospital in Chelsea.
He also works with the Department of Health, The National Institute for Health and Care Excellence, the Quality Care Commission, and the Department of Transport (Medical Advisory Panel).
A founding member and past-Chair of the British Society for Heart Failure, he has also sat on the Board of the Heart Failure Association of the European Society of Cardiology. He is a member of the European Society of Cardiology’s EU Affairs Committee, and sits on the strategic Cardiovascular Roundtable of that organisation.
His major clinical and research interests are in health technology assessment and the delivery of efficient and effective care for patients with heart failure, with a particular focus on new technologies: diagnostics, drugs or devices.
Professor Cowie lectures widely in the UK and internationally on cardiovascular disease, and organises many multi-professional educational events. He advises industry at all stages in the lifecycle of innovative products that can help improve the life-expectancy and quality of life of people with heart failure. He has chaired the NIHR NW London Comprehensive Local Research Network for the past six years, and was a Senior Investigator with NIHR from 2007-12.
As well as writing chapters for medical textbooks, including sections on heart failure for the Oxford Textbook of Medicine, Cardiovascular Medicine, and Essential Cardiology, Professor Cowie has published widely in cardiovascular medical journals (please see publication list). He is also frequently interviewed in the national media regarding heart issues, and particularly enjoys talking to the public about heart matters, working alongside the Wellcome Collection, the Cambridge Science Festival and other educational bodies.
Department Cardiology, Kerckhoff-Klinik, Bad Nauheim, Germany
He became Associate Professor in Internal Medicine and Cardiology at the University Hospital in Hamburg in 1989, before becoming Medical Director and Chief of Cardiology at the Kerckhoff Heart Center, Bad Nauheim, Germany, in 1999. He was holding the Kerckhoff Foundation Professorship at the University of Frankfurt and since 2011 he became Director of the Medical Clinic I at the University of Giessen, Germany.
His major research interests include acute coronary syndromes, cardiac biomarkers, cardiac MRI and CT, and interventional cardiology. He has been the principal investigator for many clinical studies and serves on several steering committees in multicenter trials. He has published over 400 articles in peer-reviewed journals and is on the editorial boards of numerous journals like European Heart Journal, Journal of the American College of Cardiology, Clinical Research in Cardiology, Cardiology International, Emergency Care, Current Cardiology Reviews, the International Journal of Cardiovascular Interventions and Clinical Cardiology. He served on several ESC guideline committees and chaired the ESC Guideline on Non-ST Elevation ACS.
Professor Hamm is a fellow of the German Cardiac Society and the German Society of Internal Medicine, as well as the European Society of Cardiology, the American College of Cardiology, and the American Heart Association. He served on the Board of the European Society of Cardiology, was in 2012 Congress President of the German Society of Cardiothoracic Surgery, and is current President of the German Cardiac Society.
Medical University of Vienna, Department of Internal Medicine II, Cardiology, Vienna, Austria
Since 2008 Deputy director of the Clinical Department of Cardiology
Since 2014 Head of Cardiac Catheterization Laboratory
2004 Professor of Vascular Biology
1994-2008 Head of the Pulmonary Hypertension Outpatient Clinic
Linnaeus University, Kalmar, Sweden
He is a clinical cardiologist with specific interest in the role of lifestyle on cardiovascular disease in all age groups. Professor Perks’ main interest of research is in the field of prevention and cardiac rehabilitation. He has numerous publications in this field. Furthermore he is one of the founders of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR), a daughter branch of the European Society of Cardiology (ESC).
He is chairman of the Joint European Societies’ Taskforce on Cardiovascular Prevention in Clinical Practice which has published the 2012 European Guidelines on CVD Prevention. In addition he is chairman of the Prevention Implementation Committee of the EACPR, editor of the Eur J of Preventive Cardiology, member of the ESC press committee and has annual assignments in tropical medicine, Zambia.
Department of Internal Medicine, Robert Bosch Hospital Stuttgart, Germany
1969 – 1975 Electrical engineering studies at TU Hannover, Diploma 1975, academic title “Diplom-Ingenieur”
1975 – 1981 Medical studies (Medizinische Hochschule Hannover, Glasgow University, University of Cologne)
1981 State graduation examination in Medicine1983Academic title “Dr. med.” with the thesis “Long term results after gastrectomy”
1989 Habilitation for Internal Medicine with the thesis “Evaluation of cardiac function using magnetic resonance imaging”
1997 Associate Professor of Medicine and Cardiology, University of Cologne
1988 Board examination in Internal Medicine
1990 Board examination in Cardiology
1982 – 1985 Residency, Department of Internal Medicine, University of Aachen
1985 – 1986 Fellow in cardiac MRI, Department of Radiology, UCSF
1987 – 1989 Residency, Department of Internal Medicine, University of Cologne
1995 Assistant Professor of Medicine and Cardiology, Klinik III für Innere Medizin, University of Cologne; investigator in clinical studies
Since 1997 Chief of Cardiology, Robert Bosch Hospital Stuttgart
Since 1998 Associate Professor of Medicine and Cardiology, University of Tübingen
Key research areas
Functional coronary artery disease
Magnetic resonance imaging
Coronary computed tomography
3rd Division of Cardiology, Medical University of Silesia, Katowice, Poland
King’s College London, King’s College Hospital, London, UK
In 2004 Professor Wendler was appointed at King’s College Hospital, and held the position of clinical director for cardiovascular services from 2006 until 2012, when he was promoted Professor of Cardiac Surgery at King’s College London.
Professor Wendler has a particular interests in the treatment of heart valve disease and is sub-specialised in valve repair techniques including the aortic root, mitral and tricuspid valve. Due to his particular expertise in this area, Professor Wendler runs a service particularly specialised in the treatment of complex multiple heart valve surgery including patients with carcinoid disease. Through his close collaboration with the vascular surgical department and interventional radiology he has also established King’s College Hospital as one of the major centers for thoracic aortic surgery.
In 2007 Professor Wendler performed the first transapical Transcatheter Aortic Valve Implantation (TAVI) in the UK and has established King’s College Hospital as one of the major international centers for this innovative treatment. Over recent years the King’s Heart Team performed the first TAVI in a failing aortic bioprosthesis (2008), the first transcatheter valve implantation in a failing mitral bioprosthesis (2010) and the worlds first non-predilation transapical TAVI in 2011.
Most recent developments of the King’s Heart Team focus on patients with ischemic cardiomyopathy and the treatment of patients with functional mitral regurgitation as a result of left ventricular dysfunction. The first minimal invasive surgery on a patient with a left ventricular aneurysm using the LIVE (Less Invasive Ventricular Enhancement) procedure was performed at King’s in 2013 and new minimally invasive treatment for mitral regurgitation is awaited soon.
Jose L. Zamorano
Department of Cardiology, University Hospital Ramón y Cajal, Madrid, Spain
1987 Medical Doctor, University Complutense, Madrid
1991 Doctor in Medicine – Cum Laude
1993 Specialist in Cardiology
1998 Assoc. Prof. of Medicine
2006 Management and Health resources (ESADE business school Madrid)
2007 Professor of Cardiology
Positions ESC and other professional organisations
1990 – 2002 President, Working Group on Non-invasive Diagnostic Imaging, Spanish Society of Cardiology
2001 – 2004 Member, Scientific Committee, European Association of Echocardiography of the European Society of Cardiology
since 2003 Member, Accreditation Committee, European Association of Echocardiography
2004 – 2008 Member, Guidelines Committee of the ESC
2006 – 2008 Member of the Board – Councillor European Society of Cardiology
2006 – 2008 President Elect European Association of Echocardiography of the ESC
since 2007 ACC International Advisor in the International Committee
2008 – 2010 Secretary of the European Society of Cardiology
2008 – 2010 President European Association of Echocardiography of the ESC
since 2012 Chair of the ESC Guidelines Committee
since 2013 President of Spanish National Research Evaluation Committee
Major research interest
Ischaemic heart disease
CV Risk factors
CV Imaging modalities